Cervical intraepithelial neoplasia grade 2
Information
- Disease name
- Cervical intraepithelial neoplasia grade 2
- Disease ID
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT04400578 | Completed | N/A | TRICIN: Prospective Study on the Efficacy of Single Topical Trichloroacetic Acid (TCA) 85% in the Treatment of Cervical Intraepithelial Neoplasia (CIN 1/2) | February 7, 2020 | January 18, 2022 |
| NCT06439433 | Completed | Phase 2 | ALA-PDT in Patients With CIN2 in p16-positivity and High-risk HPV Infection | May 31, 2021 | March 6, 2024 |
| NCT06403618 | Not yet recruiting | Evaluation of the PreCursor-M+® in CIN2 | May 15, 2024 | May 15, 2027 | |
| NCT00005808 | Terminated | Phase 1 | Photodynamic Therapy Using Lutetium Texaphyrin in Treating Patients With Cervical Intraepithelial Neoplasia | December 2000 | |
| NCT05624827 | Unknown status | N/A | The Role of FAM19A4 and Hsa-mir-124 Methylation in Predicting Prognosis of Untreated Cervical Intraepithelial Neoplasia 2 (CIN 2) | September 1, 2021 | May 1, 2024 |
| NCT01313104 | Withdrawn | N/A | Colposcopy and High Resolution Anoscopy in Screening For Anal Dysplasia in Patients With Cervical, Vaginal, or Vulvar Dysplasia or Cancer |